Global Market Access Cogentia is recognized as one of the UK's leading market access consultancies with global project experience across major therapeutic areas. This presents opportunities to win international HTA readiness, payer landscape analysis, and pricing strategy engagements for pharmaceutical, devices, diagnostics, biotech and investor clients pursuing global launches.

AI Enabled Analytics The tech stack includes OpenAI and Google Analytics, enabling AI powered market insights, forecasting, and pricing scenario modeling. This capability can be leveraged to upsell advanced analytics and decision support services to clients navigating complex payer pathways.

M A Edge Recent Alfa Corporate Finance led sale to Helios Global Group signals strong exposure to mergers and acquisitions activity in life sciences. This creates cross selling opportunities with buyers, funds, and portfolio companies requiring market access due diligence, integration planning, and portfolio optimization services.

Mid Market Growth With revenue in the one to ten million USD range and a team of 11 to 50 employees, Cogentia is well positioned to win mid sized pharma and biotech engagements. Propose scalable, modular services and longer term retainers to expand revenue while delivering high value market access programs.

Lifecycle Partnerships Cogentia spans the lifecycle from early discovery through pricing maturation and patient uptake, indicating a strong fit for ongoing managed services and recurring advisory arrangements for portfolio companies and investors seeking continuous market access support.